Clinical Updates
Drug approvals, guideline changes, and treatment advances
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Clinical Updates
Magnesium Supplements: Marketing Claims vs Scientific Evidence
Marketing claims about magnesium forms targeting specific organs lack human clinical evidence. All magnesium salts…
Steam Therapy Shows Promise for Type 2 Diabetes Treatment in Arizona Clinical Trial
HonorHealth Research Institute launches first U.S. clinical trial investigating steam therapy as novel treatment for…
Pharmacist’s Misdiagnosed Vulvar Itching Reveals Critical Need for Cancer Awareness
A pharmacist's misdiagnosis of her own persistent vulvar itching as thrush, later revealed to be…
CAR-T Cell Therapy Shows Promise for ‘Resetting’ Autoimmune Disease
CAR-T cell therapy shows remarkable promise for 'resetting' immune systems in autoimmune disease patients, with…
Machine Learning Algorithm Personalizes Depression Treatment Through Wearable Technology
New machine learning system personalizes depression treatment by analyzing wearable device data, addressing the 21%…